132 related articles for article (PubMed ID: 1911078)
1. [Cancer of the breast and the receptor status].
Buonomo O; Serao A; Muggianu A; Guglielmelli E; Davoli E; Amori A
G Chir; 1991 Apr; 12(4):274-7. PubMed ID: 1911078
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
Lee KH; Im SA; Oh DY; Lee SH; Chie EK; Han W; Kim DW; Kim TY; Park IA; Noh DY; Heo DS; Ha SW; Bang YJ
BMC Cancer; 2007 Apr; 7():63. PubMed ID: 17430582
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
[TBL] [Abstract][Full Text] [Related]
5. [Steroid hormone receptors and survival in breast cancer patients].
Ivanova OA; Tsyrlina EV; Moiseenko VM; Semiglazov VF
Vopr Onkol; 1986; 32(6):71-6. PubMed ID: 3727485
[TBL] [Abstract][Full Text] [Related]
6. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance.
Arpino G; Weiss H; Lee AV; Schiff R; De Placido S; Osborne CK; Elledge RM
J Natl Cancer Inst; 2005 Sep; 97(17):1254-61. PubMed ID: 16145046
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group.
Kyndi M; Sørensen FB; Knudsen H; Overgaard M; Nielsen HM; Overgaard J;
J Clin Oncol; 2008 Mar; 26(9):1419-26. PubMed ID: 18285604
[TBL] [Abstract][Full Text] [Related]
8. Hormone receptors and disease-free survival in breast cancer: impact of increasing threshold levels.
Di Fronzo G; Coradini D; Cappelletti V; Miodini P; Granata G; Schwartz M; Panko WB
Anticancer Res; 1990; 10(6):1699-705. PubMed ID: 2285244
[TBL] [Abstract][Full Text] [Related]
9. Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy.
Honma N; Horii R; Iwase T; Saji S; Younes M; Takubo K; Matsuura M; Ito Y; Akiyama F; Sakamoto G
J Clin Oncol; 2008 Aug; 26(22):3727-34. PubMed ID: 18669459
[TBL] [Abstract][Full Text] [Related]
10. A new look at the prognostic value of the estrogen, progesterone and epidermal growth factor receptors in breast cancer tissue.
Skasko E; Paszko Z; Mazur S
Neoplasma; 2005; 52(1):10-7. PubMed ID: 15739020
[TBL] [Abstract][Full Text] [Related]
11. [The importance of steroid receptors for the prognosis and hormone treatment of breast cancer patients: a retrospective study in Southeastern Netherlands].
Voogd AC; Crommelin MA; Repelaer van Driel OJ; Tutein Nolthenius-Puylaert MC; Vreugdenhil G; Coebergh JW
Ned Tijdschr Geneeskd; 1998 Aug; 142(31):1772-8. PubMed ID: 9856143
[TBL] [Abstract][Full Text] [Related]
12. Prognostic implications of HER-2 status in steroid receptor-positive, lymph node-negative breast carcinoma.
Peiró G; Adrover E; Aranda FI; Peiró FM; Niveiro M; Sánchez-Payá J
Am J Clin Pathol; 2007 May; 127(5):780-6. PubMed ID: 17439837
[TBL] [Abstract][Full Text] [Related]
13. [Long-term prognostic role of steroid receptors in cancer of the breast].
Broët P; Pichon MF; Magdelenat H; Delarue JC; Spyratos F; Basuyau JP; Saez S; Rallet A; Courrière P; Millon R; Asselain B
Bull Cancer; 1998 Apr; 85(4):347-52. PubMed ID: 9752299
[TBL] [Abstract][Full Text] [Related]
14. Correlation of clinical, pathological status, hormone receptor and C-erbB-2 oncoprotein in breast cancer patients.
Aryandono T; Harijadi ; Ghozali A
Gan To Kagaku Ryoho; 2000 May; 27 Suppl 2():600-6. PubMed ID: 10895217
[TBL] [Abstract][Full Text] [Related]
15. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
16. Assessment of results of estrogen and progesterone receptor assays performed in a community hospital.
Szakacs JG; Arroyo JG; Girgenti AJ
Ann Clin Lab Sci; 1986; 16(4):266-73. PubMed ID: 3740795
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.
Foekens JA; Portengen H; van Putten WL; Peters HA; Krijnen HL; Alexieva-Figusch J; Klijn JG
Cancer Res; 1989 Nov; 49(21):5823-8. PubMed ID: 2676151
[TBL] [Abstract][Full Text] [Related]
18. Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.
Bhatavdekar JM; Patel DD; Karelia NH; Trivedi SN; Shah NG; Vora HH; Ghosh N; Balar DB
Neoplasma; 1992; 39(6):349-52. PubMed ID: 1491724
[TBL] [Abstract][Full Text] [Related]
19. Tumor-proliferative activity, progesterone receptor status, estrogen receptor level, and clinical outcome of estrogen receptor-positive advanced breast cancer.
Paradiso A; Tommasi S; Mangia A; Lorusso V; Simone G; De Lena M
Cancer Res; 1990 May; 50(10):2958-62. PubMed ID: 2334898
[TBL] [Abstract][Full Text] [Related]
20. Estrogen and progesterone receptors status in Thai female breast cancer patients: an analysis of 399 cases at King Chulalongkorn Memorial Hospital.
Lertsanguansinchai P; Chottetanaprasith T; Chatamra K; Sampatanukul P; Wannakrairot P; Rojpornpradit P; Shotelersuk K; Lertbutsayanukul C; Boonjunwetwat D; Vajragupta L
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S193-202. PubMed ID: 12188412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
